ARCHIVES

Gynecologic Oncology Group To Conduct Phase III Trial of Xyotax For Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 27 No. 4 | April 30, 2004

Download PDF Visit The Full Archive

Related Articles

Breast Cancer Rates Decline Most for Affluent White Women

February 26, 2010

NCI Increases R01 Grant Payline From 12th to 15th Percentile.

June 29, 2007

NCI Signs Letters Of Intent With Latin American Countries

October 2, 2009

Reviewers Report Progress In New Drug Prescreen System Development, Commend DTP

December 15, 1989

In Brief: Fredrickson Will Stay As NIH Director; NCI Group to Study Rhoads’ Clinical Center Idea

February 11, 1977

NCI Accused Of forsaking Its Mission In House Hearing On Screening Statement

March 18, 1994